76) Weiqi Cai, Ji Liu, Xianghan Chen, Lanqun Mao, Ming Wang*, Orthogonal Chemical Activation of Enzyme-Inducible CRISPR/Cas9 for Cell-Selective Genome Editing, J. Am. Chem. Soc. 2022, 144, 22272-22280.

          

75) Tianli Luo, Qizhen Zheng, Leihou Shao, Tianyu Ma, Lanqun Mao, Ming Wang*, Intracellular Delivery of Glutathione Peroxidase Degrader Induces Ferroptosis In Vivo, Angew. Chem. Int. Ed., 2022, 61, e202206277.

74) Chunjing Liang, Qizhen Zheng, Tianli Luo, Weiqi Cai, Lanqun Mao, Ming Wang*, Enzyme-catalyzed activation of Pro-PROTAC for cell-selective protein degradation. CCS Chemistry, 2022, 4, 3809-3819.

73) Weiqi Cai, Tianli Luo, Xianghan Chen, Lanqun Mao, Ming Wang*, A Combinatorial Library of Biodegradable Lipid Nanoparticles Preferentially Deliver mRNA into Tumor Cells to Block Mutant RAS Signaling, Adv. Funct. Mater., 2022, 32, 2204947.

72) Shuhan Liu, Ji Liu, Haisong Liu,Kuirong Mao, Haorui Wang, Xiandi Meng, Jialiang Wang, Chenxi Wu, Hongmei Chen, Xin Wang, Xiuxiu Cong, Yue Hou, Ye Wang, Ming Wang*, Yong-guang Yang*, Tianmeng Sun*, A Novel Ionizable Cationic Lipid for Brain Tumor-targeted siRNA Delivery and Glioblastoma Immunotherapy, Biomaterials, 2022, 287, 121645.

71) Xianghan Chen, Weiqi Cai, Ji Liu, Lanqun Mao, Ming Wang*, Integration of Palladium nanoparticles with surface engineered metal-organic frameworks for cell-selective bioorthogonal catalysis and protein activity regulation. ACS Appl. Mater. Interface 2022, 14, 10117-10124.

70) Anqi Liu, Chunjing Liang, Ji Liu, Yifei Huang*, Ming Wang*, Liqiang Wang*, Reactive oxygen species(ROS)-responsive lipid nanoparticles for effective RNAi and corneal neovascularizaiton therapy. ACS Appl. Mater. Interface 2022, 14, 17022-17031.